Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

Infertility in Females

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...

Infertility in Males

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Women's and men's health strategies offer a shared agenda for reform.

BMJ (Clinical research ed.)·2026

Same author

Equity and Respect in Maternal and Infant Healthcare-A Report From the 2025 Venice Forum.

Acta paediatrica (Oslo, Norway : 1992)·2026

Same author

Why investing in women's health is a societal imperative.

Lancet (London, England)·2026

Same author

Ending the taboo on periods and period problems.

Nature medicine·2025

Same author

Abortion law reform in the UK.

BMJ (Clinical research ed.)·2025

Same author

Characterisation and comparison of semen microbiota and bacterial load in men with infertility, recurrent miscarriage, or proven fertility.

eLife·2025

Search research articles

Related Experiment Video

Updated: May 3, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

Unexplained recurrent pregnancy loss.

Sotirios H Saravelos¹, Lesley Regan¹

¹Department of Obstetrics and Gynaecology, St Mary's Campus, Imperial College London, Mint Wing, South Wharf Road, London W2 1PG, UK.

Obstetrics and Gynecology Clinics of North America

|February 5, 2014

Summary

This summary is machine-generated.

Women with unexplained recurrent pregnancy loss (RPL) are diverse. Stratifying patients by their likelihood of a pathologic status aids in selecting appropriate investigations and treatments for recurrent pregnancy loss.

Keywords:

Idiopathic Miscarriage Pregnancy loss Recurrent Unexplained

More Related Videos

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

Related Experiment Videos

Last Updated: May 3, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

Area of Science:

Reproductive immunology
Reproductive medicine
Genetics

Background:

Unexplained recurrent pregnancy loss (RPL) affects a heterogeneous patient population.
Previous research explored endocrine and immune factors.
Recent studies investigate spermatozoal, embryonic, and endometrial factors influencing implantation and pregnancy loss.

Purpose of the Study:

To stratify women with unexplained RPL based on their probability of a pathologic status.
To identify patient subgroups most suitable for further investigation and targeted treatments.

Main Methods:

Review of existing literature on RPL.
Analysis of factors affecting implantation and pregnancy.
Development of a stratification framework for unexplained RPL patients.

Main Results:

Identification of key spermatozoal, embryonic, and endometrial factors.
Establishment of criteria for stratifying RPL patients.
Potential for improved diagnostic and therapeutic pathways.

Conclusions:

Stratification of unexplained RPL patients is crucial for personalized medicine.
This approach will optimize the selection of patients for further research and clinical interventions.
A refined understanding of RPL pathophysiology can lead to better patient outcomes.